REGN : REGENERON PHARMACEUTICALS stock forecast, predictions, and share price target 2025 - 2026 - 2030 - 2035 with analysis
| year | Average | Low | High | Change from close on 2025-01-17 |
|---|---|---|---|---|
| 2025 | $663.87 | $648.29 | $678.69 | -2.6% |
| 2026 | $712.24 | $588.82 | $770.59 | 4.5% |
| 2027 | $451.05 | $406.14 | $532.85 | -33.82% |
| 2028 | $326.15 | $293.55 | $393.96 | -52.15% |
| 2029 | $289.86 | $284.6 | $294.41 | -57.47% |
| 2030 | $292.56 | $285.28 | $296.36 | -57.08% |
| 2031 | $282.04 | $275.39 | $293.3 | -58.62% |
| 2032 | $277.46 | $270.67 | $282.61 | -59.29% |
| 2033 | $273.78 | $269.83 | $276.91 | -59.83% |
| 2034 | $272.07 | $268.66 | $274.49 | -60.08% |
| 2035 | $268.08 | $268.08 | $268.08 | -60.67% |
The 44 Wall Street analysts offering REGENERON PHARMACEUTICALS stock forecast in the last 6 months have average price target of
$1098.16 with a high forecast of $1300.0 and a low forecast of $165.0.
The average REGENERON PHARMACEUTICALS stock forecast represents a 61.12%
increase from the last price of $681.580017089844.
For REGENERON PHARMACEUTICALS stock forecast for 2025, 11 predictions are offered for each month of 2025 with average REGENERON PHARMACEUTICALS stock
forecast of $663.87, a high forecast of $678.69, and a low forecast of $648.29.
The average REGENERON PHARMACEUTICALS stock forecast 2025 represents a -2.6%
decrease from the last price of $681.580017089844.
For REGENERON PHARMACEUTICALS stock forecast for 2026, 12 predictions are offered for each month of 2026 with average REGENERON PHARMACEUTICALS stock
forecast of $712.24, a high forecast of $770.59, and a low forecast of $588.82.
The average REGENERON PHARMACEUTICALS stock forecast 2026 represents a 4.5%
increase from the last price of $681.580017089844.
For REGENERON PHARMACEUTICALS stock forecast for 2028, 12 predictions are offered for each month of 2028 with average REGENERON PHARMACEUTICALS stock
forecast of $326.15, a high forecast of $393.96, and a low forecast of $293.55.
The average REGENERON PHARMACEUTICALS stock forecast 2028 represents a -52.15%
decrease from the last price of $681.580017089844.
For REGENERON PHARMACEUTICALS stock forecast for 2030 (5 year), 12 predictions are offered for each month of 2030 with average REGENERON PHARMACEUTICALS stock
forecast of $292.56, a high forecast of $296.36, and a low forecast of $285.28.
The average REGENERON PHARMACEUTICALS stock forecast 2030 represents a -57.08%
decrease from the last price of $681.580017089844.
For REGENERON PHARMACEUTICALS stock forecast 2031, 12 predictions are offered for each month of 2031 with average REGENERON PHARMACEUTICALS stock
forecast of $282.04, a high forecast of $293.3, and a low forecast of $275.39.
The average REGENERON PHARMACEUTICALS stock forecast 2031 represents a -58.62%
decrease from the last price of $681.580017089844.
For REGENERON PHARMACEUTICALS stock forecast for 2035 (10 year), 1 predictions are offered for each month of 2035 with average REGENERON PHARMACEUTICALS stock
forecast of $268.08, a high forecast of $268.08, and a low forecast of $268.08.
The average REGENERON PHARMACEUTICALS stock forecast 2035 represents a -60.67%
decrease from the last price of $681.580017089844.
Please, see more forecasts below.
REGN : REGENERON PHARMACEUTICALS stock forecast by Wall Street Analysts
The average REGENERON PHARMACEUTICALS stock forecast from last 6 month is $1098.16, and this show a -2.44% decrease in average from the prior price target of the each prediction. Also, this average forecast of $1098.16 represents a -0.02% decrease from the past average forecast of $1098.38, 6 months ago from 29 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2025-01-16 | UBS | $1130.0000 | $738.0000 | Neutral |
| 2025-01-14 | Citigroup | $895.00 | $795.0000 | Neutral |
| 2025-01-10 | Wells Fargo | $1050.00 | $900.0000 | Overweight |
| 2025-01-08 | Truist Securities | $1126.00 | $1004 | Buy |
| 2025-01-07 | Bernstein | $1110.0000 | $1070.0000 | Outperform |
| 2024-12-17 | Canaccord Genuity | $165.0000 | Hold | |
| 2024-12-10 | B of A Securities | $565 | Underperform | |
| 2024-11-15 | Wolfe Research | $1150.0000 | Outperform | |
| 2024-11-14 | Citigroup | $895.0000 | Neutral | |
| 2024-11-06 | Oppenheimer | $1150.0000 | $1000 | Outperform |
| 2024-11-01 | Truist Securities | $1137.00 | $1126 | Buy |
| 2024-11-01 | BMO Capital | $1300.00 | $1190 | Outperform |
| 2024-11-01 | Piper Sandler | $1242.00 | $1195 | Overweight |
| 2024-11-01 | Barclays | $1080.00 | $1065.0000 | Overweight |
| 2024-11-01 | RBC Capital | $1260.00 | $1215.00 | Outperform |
| 2024-11-01 | Morgan Stanley | $1235.0000 | $1184 | Overweight |
| 2024-10-25 | RBC Capital | $1260.00 | $1260.00 | Outperform |
| 2024-10-24 | JP Morgan | $1200.00 | $1150.0000 | Overweight |
| 2024-10-24 | Evercore ISI Group | $1250.0000 | $1175 | Outperform |
| 2024-10-23 | Barclays | $1220.0000 | $1080.0000 | Overweight |
| 2024-10-23 | Cantor Fitzgerald | $1015.00 | $1015.00 | Neutral |
| 2024-10-22 | RBC Capital | $1260.00 | $1260.0000 | Outperform |
| 2024-10-22 | Wells Fargo | $1200.00 | $1050.0000 | Overweight |
| 2024-10-16 | Truist Securities | $1200.00 | $1137 | Buy |
| 2024-10-04 | RBC Capital | $1252.00 | $1260.0000 | Outperform |
| 2024-09-24 | BMO Capital | $1300.0000 | $1300 | Outperform |
| 2024-09-24 | RBC Capital | $1282.0000 | $1252.0000 | Outperform |
| 2024-09-24 | Truist Securities | $1200.00 | $1200 | Buy |
| 2024-09-24 | Leerink Partners | $1175.0000 | $1077.0000 | Market Perform |
| 2024-09-23 | Wells Fargo | $1200.00 | $1200.0000 | Overweight |
| 2024-09-17 | RBC Capital | $1282.0000 | $1282.0000 | Outperform |
| 2024-09-16 | Cantor Fitzgerald | $1015.00 | $1015.0000 | Neutral |
| 2024-09-09 | RBC Capital | $1250.00 | $1282.00 | Outperform |
| 2024-09-09 | Cantor Fitzgerald | $1015.0000 | $1015.0000 | Neutral |
| 2024-09-05 | RBC Capital | $1250.0000 | $1250.00 | Outperform |
| 2024-08-23 | Piper Sandler | $1166.00 | $1242 | Overweight |
| 2024-08-02 | Truist Securities | $1135.00 | $1200.0000 | Buy |
| 2024-08-02 | Barclays | $1200.00 | $1220.0000 | Overweight |
| 2024-08-02 | Wells Fargo | $1125.0000 | $1200.0000 | Overweight |
| 2024-08-02 | Guggenheim | $1180.00 | $1300.00 | Buy |
| 2024-08-02 | RBC Capital | $1232.0000 | $1240 | Outperform |
| 2024-08-02 | JP Morgan | $1150.00 | $1200.0000 | Overweight |
| 2024-07-23 | TD Cowen | $1030.00 | $1200.0000 | Buy |
| 2024-07-22 | Cantor Fitzgerald | $925.00 | $1000.0000 | Neutral |
| 2024-07-19 | Piper Sandler | $1000.0000 | $1166 | Overweight |
| 2024-07-18 | Guggenheim | $1040.0000 | $1180.0000 | Buy |
| 2024-07-11 | Morgan Stanley | $1183.0000 | $1182 | Overweight |
| 2024-07-10 | Barclays | $1050.0000 | $1200.0000 | Overweight |
| 2024-06-27 | Canaccord Genuity | $1152.0000 | $1152.0000 | Buy |
| 2024-06-25 | Argus Research | $1060.0000 | $1170.0000 | Buy |
| 2024-06-24 | RBC Capital | $1229.00 | $1229.00 | Outperform |
| 2024-06-17 | JP Morgan | $1050.0000 | $1150.0000 | Overweight |
| 2024-06-12 | RBC Capital | $1200.0000 | $1229.0000 | Outperform |
| 2024-06-04 | RBC Capital | $1185.0000 | $1200.00 | Outperform |
| 2024-05-14 | Evercore ISI Group | $1150.0000 | Outperform | |
| 2024-05-03 | Cantor Fitzgerald | $925.0000 | Neutral | |
| 2024-04-24 | TD Cowen | $1020.0000 | $1030.0000 | Buy |
| 2024-04-17 | UBS | $1090.0000 | $1099.0000 | Buy |
| 2024-04-17 | Cantor Fitzgerald | $925.0000 | Neutral | |
| 2024-04-15 | Cantor Fitzgerald | $925.0000 | Neutral | |
| 2024-04-12 | B of A Securities | $710.0000 | $720.0000 | Underperform |
| 2024-04-09 | RBC Capital | $1189.0000 | Outperform | |
| 2024-04-03 | Truist Securities | $1135.00 | $1135 | Buy |
| 2024-03-26 | Truist Securities | $1135.0000 | $1135 | Buy |
| 2024-03-13 | Morgan Stanley | $1104.0000 | $1115 | Overweight |
| 2024-03-12 | Bernstein | $1125.0000 | Outperform | |
| 2024-03-11 | Bernstein | $1125.0000 | Outperform | |
| 2024-02-27 | RBC Capital | $1096.0000 | $1184.0000 | Outperform |
| 2024-02-06 | Cantor Fitzgerald | $850.0000 | $925.0000 | Neutral |
| 2024-02-05 | BMO Capital | $1055.0000 | $1082.00 | Outperform |
| 2024-02-05 | RBC Capital | $1076.00 | $1110.0000 | Outperform |
| 2024-01-29 | RBC Capital | $1076.0000 | Outperform | |
| 2024-01-23 | Barclays | $935.0000 | $1020 | Overweight |
REGENERON PHARMACEUTICALS stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2025-01-20 | $674.55 | -1.03% |
| 2025-01-21 | $679.23 | 0.69% |
| 2025-01-22 | $675.07 | -0.61% |
| 2025-01-23 | $680.50 | 0.80% |
| 2025-01-24 | $681.11 | 0.09% |
REGN : Long term REGENERON PHARMACEUTICALS stock forecast for 2025 - 2026 - 2030 - 2035
Forecast for 2025 Feb. is $674.26 , for 2026 Jan. is $684.34 , for 2029 Jan. is $294.15 , for 2030 Jan. is $285.28 , for 2034 Jan. is $270.00 , and for 2035 Jan. is $268.08.
REGN : REGENERON PHARMACEUTICALS stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Feb. | $674.26 | -1.07% |
| 2025 Mar. | $665.20 | -1.34% |
| 2025 Apr. | $657.49 | -1.16% |
| 2025 May. | $652.72 | -0.73% |
| 2025 Jun. | $648.70 | -0.61% |
| 2025 Jul. | $648.29 | -0.06% |
| 2025 Aug. | $654.66 | 0.98% |
| 2025 Sep. | $667.84 | 2.01% |
| 2025 Oct. | $676.16 | 1.24% |
| 2025 Nov. | $678.53 | 0.35% |
| 2025 Dec. | $678.69 | 0.02% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $684.34 | 0.83% |
| 2026 Feb. | $697.01 | 1.85% |
| 2026 Mar. | $716.25 | 2.76% |
| 2026 Apr. | $741.33 | 3.50% |
| 2026 May. | $761.45 | 2.71% |
| 2026 Jun. | $770.59 | 1.20% |
| 2026 Jul. | $770.19 | -0.05% |
| 2026 Aug. | $752.60 | -2.28% |
| 2026 Sep. | $727.72 | -3.31% |
| 2026 Oct. | $691.18 | -5.02% |
| 2026 Nov. | $645.46 | -6.61% |
| 2026 Dec. | $588.82 | -8.77% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $532.85 | -9.51% |
| 2027 Feb. | $489.82 | -8.08% |
| 2027 Mar. | $467.24 | -4.61% |
| 2027 Apr. | $459.86 | -1.58% |
| 2027 May. | $455.20 | -1.01% |
| 2027 Jun. | $450.44 | -1.05% |
| 2027 Jul. | $445.41 | -1.12% |
| 2027 Aug. | $438.81 | -1.48% |
| 2027 Sep. | $430.17 | -1.97% |
| 2027 Oct. | $421.92 | -1.92% |
| 2027 Nov. | $414.71 | -1.71% |
| 2027 Dec. | $406.14 | -2.07% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $393.96 | -3.00% |
| 2028 Feb. | $377.90 | -4.08% |
| 2028 Mar. | $360.63 | -4.57% |
| 2028 Apr. | $342.53 | -5.02% |
| 2028 May. | $328.70 | -4.04% |
| 2028 Jun. | $317.25 | -3.48% |
| 2028 Jul. | $309.40 | -2.47% |
| 2028 Aug. | $303.49 | -1.91% |
| 2028 Sep. | $297.97 | -1.82% |
| 2028 Oct. | $294.78 | -1.07% |
| 2028 Nov. | $293.55 | -0.42% |
| 2028 Dec. | $293.61 | 0.02% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $294.15 | 0.19% |
| 2029 Feb. | $294.41 | 0.09% |
| 2029 Mar. | $293.81 | -0.20% |
| 2029 Apr. | $292.69 | -0.38% |
| 2029 May. | $291.80 | -0.31% |
| 2029 Jun. | $291.10 | -0.24% |
| 2029 Jul. | $290.03 | -0.37% |
| 2029 Aug. | $288.52 | -0.52% |
| 2029 Sep. | $286.92 | -0.56% |
| 2029 Oct. | $285.54 | -0.48% |
| 2029 Nov. | $284.70 | -0.30% |
| 2029 Dec. | $284.60 | -0.03% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $285.28 | 0.24% |
| 2030 Feb. | $286.61 | 0.47% |
| 2030 Mar. | $288.37 | 0.61% |
| 2030 Apr. | $290.30 | 0.67% |
| 2030 May. | $292.15 | 0.64% |
| 2030 Jun. | $293.74 | 0.54% |
| 2030 Jul. | $294.98 | 0.42% |
| 2030 Aug. | $295.84 | 0.29% |
| 2030 Sep. | $296.33 | 0.16% |
| 2030 Oct. | $296.36 | 0.01% |
| 2030 Nov. | $295.87 | -0.17% |
| 2030 Dec. | $294.83 | -0.35% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $293.30 | -0.52% |
| 2031 Feb. | $291.34 | -0.67% |
| 2031 Mar. | $289.01 | -0.80% |
| 2031 Apr. | $286.42 | -0.90% |
| 2031 May. | $283.70 | -0.95% |
| 2031 Jun. | $281.05 | -0.94% |
| 2031 Jul. | $278.69 | -0.84% |
| 2031 Aug. | $276.85 | -0.66% |
| 2031 Sep. | $275.72 | -0.41% |
| 2031 Oct. | $275.39 | -0.12% |
| 2031 Nov. | $275.88 | 0.18% |
| 2031 Dec. | $277.08 | 0.44% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $278.75 | 0.60% |
| 2032 Feb. | $280.50 | 0.63% |
| 2032 Mar. | $281.91 | 0.50% |
| 2032 Apr. | $282.61 | 0.25% |
| 2032 May. | $282.36 | -0.09% |
| 2032 Jun. | $281.10 | -0.45% |
| 2032 Jul. | $278.99 | -0.75% |
| 2032 Aug. | $276.39 | -0.93% |
| 2032 Sep. | $273.79 | -0.94% |
| 2032 Oct. | $271.75 | -0.75% |
| 2032 Nov. | $270.67 | -0.40% |
| 2032 Dec. | $270.69 | 0.01% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $271.67 | 0.36% |
| 2033 Feb. | $273.24 | 0.58% |
| 2033 Mar. | $274.91 | 0.61% |
| 2033 Apr. | $276.23 | 0.48% |
| 2033 May. | $276.91 | 0.25% |
| 2033 Jun. | $276.85 | -0.02% |
| 2033 Jul. | $276.06 | -0.28% |
| 2033 Aug. | $274.71 | -0.49% |
| 2033 Sep. | $273.08 | -0.60% |
| 2033 Oct. | $271.51 | -0.58% |
| 2033 Nov. | $270.35 | -0.43% |
| 2033 Dec. | $269.83 | -0.19% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $270.00 | 0.06% |
| 2034 Feb. | $270.73 | 0.27% |
| 2034 Mar. | $271.79 | 0.39% |
| 2034 Apr. | $272.90 | 0.41% |
| 2034 May. | $273.85 | 0.35% |
| 2034 Jun. | $274.44 | 0.21% |
| 2034 Jul. | $274.49 | 0.02% |
| 2034 Aug. | $273.93 | -0.20% |
| 2034 Sep. | $272.82 | -0.41% |
| 2034 Oct. | $271.35 | -0.54% |
| 2034 Nov. | $269.85 | -0.55% |
| 2034 Dec. | $268.66 | -0.44% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2035
| Date | Price Target | Change |
|---|---|---|
| 2035 Jan. | $268.08 | -0.22% |
Frequently Asked Questions about REGENERON PHARMACEUTICALS stock forecast
Is REGENERON PHARMACEUTICALS a good long term stock?
From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock cannot be a good investment choice. According to AIPickup, the REGENERON PHARMACEUTICALS stock price forecast for 2025 Feb. is $674.256229280866 From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock can be a good investment choice. According to AIPickup, the REGENERON PHARMACEUTICALS stock price forecast for 2026 Jan. is $684.340331719366 From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock cannot be a good investment choice. According to AIPickup, the REGENERON PHARMACEUTICALS stock price forecast for 2029 Jan. is $294.151312650882 From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock cannot be a good investment choice. According to AIPickup, the REGENERON PHARMACEUTICALS stock price forecast for 2030 Jan. is $285.280595945276 From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock cannot be a good investment choice. According to AIPickup, the REGENERON PHARMACEUTICALS stock price forecast for 2034 Jan. is $269.995657298323 From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock cannot be a good investment choice. According to AIPickup, the REGENERON PHARMACEUTICALS stock price forecast for 2035 Jan. is $268.082168499215
Is REGENERON PHARMACEUTICALS stock overvalued?
REGENERON PHARMACEUTICALS (REGN) stock is expected to go UP . Therefore, AIPickup would say that REGENERON PHARMACEUTICALS (REGN) stock is NOT overvalued.
Will REGENERON PHARMACEUTICALS stock price go up?
Yes. The REGENERON PHARMACEUTICALS stock price forecast for 2026 Jan. is $684.340331719366
Is REGENERON PHARMACEUTICALS stock a good buy now?
Since closing price on 2025-01-17 is $681.580017089844 and forecast for 2026 Jan. is $684.34, REGENERON PHARMACEUTICALS stock is a good 1 year investment.
14 Days Historical Data for REGENERON PHARMACEUTICALS stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| REGN stock price for 2024-12-27 | $712.40 | $710.52 | $709.09 | $718.99 |
| REGN stock price for 2024-12-30 | $702.59 | $708.04 | $700.42 | $708.97 |
| REGN stock price for 2024-12-31 | $712.33 | $703.90 | $703.39 | $713.00 |
| REGN stock price for 2025-01-02 | $715.19 | $720.86 | $711.92 | $726.81 |
| REGN stock price for 2025-01-03 | $718.15 | $716.07 | $714.76 | $722.00 |
| REGN stock price for 2025-01-06 | $716.26 | $715.00 | $713.75 | $733.69 |
| REGN stock price for 2025-01-07 | $730.30 | $716.34 | $716.34 | $734.44 |
| REGN stock price for 2025-01-08 | $733.59 | $728.04 | $725.60 | $743.28 |
| REGN stock price for 2025-01-10 | $696.88 | $721.33 | $691.00 | $724.73 |
| REGN stock price for 2025-01-13 | $716.90 | $669.24 | $666.25 | $717.37 |
| REGN stock price for 2025-01-14 | $690.87 | $714.01 | $686.00 | $715.98 |
| REGN stock price for 2025-01-15 | $703.43 | $700.61 | $698.20 | $712.60 |
| REGN stock price for 2025-01-16 | $693.23 | $701.04 | $691.33 | $706.54 |
| REGN stock price for 2025-01-17 | $681.58 | $705.34 | $680.89 | $707.48 |